Flupenthixol decanoate and injection site abscesses in an obese patient.
Andrade
Chittaranjan
C
D000038:Abscess / Q000209:etiology*; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002081:Buttocks; D003692:Delayed-Action Preparations; D005475:Flupenthixol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects*; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008297:Male; D009765:Obesity / Q000150:complications*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; C007761:flupenthixol decanoate; D005475:Flupenthixol